CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE-II - AN AUTOSOMAL RECESSIVE N-ACETYLGLUCOSAMINYLTRANSFERASE-II DEFICIENCY DIFFERENT FROM TYPICAL HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY, WITH A POSITIVE ACIDIFIED-SERUM LYSIS TEST (HEMPAS)
Jhm. Charuk et al., CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE-II - AN AUTOSOMAL RECESSIVE N-ACETYLGLUCOSAMINYLTRANSFERASE-II DEFICIENCY DIFFERENT FROM TYPICAL HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY, WITH A POSITIVE ACIDIFIED-SERUM LYSIS TEST (HEMPAS), European journal of biochemistry, 230(2), 1995, pp. 797-805
Carbohydrate-deficient glycoprotein syndromes (CDGS) are a family of m
ultisystemic congenital diseases resulting in underglycosylated glycop
roteins, suggesting defective N-glycan assembly. Fibroblast extracts f
rom two patients with a recently described variant of this disease (CD
GS type II) have previously been shown to have over 98% reduced activi
ty of UDP-GlcNAc:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltran
sferase II [GlcNAc-TII; Jaeken, J., Schachter, H., Carchon, H., De Coc
k, P., Coddeville, B. and Spik, G. (1994) Arch. Dis. Childhood 71, 123
-127]. We show in this paper that mononuclear cell extracts from one o
f these CDGS type-II patients have no detectable GlcNAc-TII activity a
nd that similar extracts from 12 blood relatives of the patient, inclu
ding his father, mother and brother, have GlcNAc-TII levels 32-67% tha
t of normal levels (average 50.1% +/- 10.7% SD), consistent with an au
tosomal recessive disease. The poly(N-acetyllactosamine) content of er
ythrocyte membrane glycoproteins bands 3 and 4.5 of this CDGS patient
were estimated, by tomato lectin blotting, to be reduced by 50% relati
ve to samples obtained from blood relatives and normal controls. Simil
ar to patients with hereditary erythroblastic multinuclearity with a p
ositive acidified-serum lysis test (HEMPAS), erythrocyte membrane glyc
oproteins in the CDGS patient have increased reactivities with concana
valin A, demonstrating the presence of hybrid or oligomannose carbohyd
rate structures. However, bands 3 and 4.5 in HEMPAS erythrocytes have
almost complete lack of poly(N-acetyllactosamine). Furthermore, CDGS t
ype-II patients have a totally different clinical presentation and the
ir erythrocytes do not show the serology typical of HEMPAS, suggesting
that the genetic lesions responsible for these two diseases are possi
bly different.